ReNeuron Group PLC (RENE)

Back to homepage

Company Description

ReNeuron Group PLC was incorporated in England on June 7, 2005. The Company is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications. The Company's main therapeutic candidate is ReN001 stem cell therapy for the treatment of patients left disabled by the effects of a stroke. Its three principal stem cell therapy programmes are ReN001 for stroke disability, ReN009 stem cell therapy for critical limb ischaemia, and ReN003 stem cell therapy for retinitis pigmentosa. The Company operates under the sole business segment of development of cell-based therapies...

About Company REFS

Company REFS (Really Essential Financial Statistics) is the UK's leading stock selection tool, with a wealth of investment facts and figures you won’t find together in any other single source. No other stock selection tool tells you so much about a UK quoted company’s prospects – on one, easy-to-read page.

Here’s what a Company REFS subscription brings you, all in one complete convenient source:

  • The latest company information and fundamental data from the London Stock Exchange - updated daily
  • Coverage of ALL 1700+ UK listed and domiciled stocks (excluding investment trusts) - including AIM
  • Uniform presentation of data - for easy like-for-like comparison of companies
  • Directors' share-dealing transactions over the last six months
  • League tables that instantly compare a company’s performance within its index against the market overall
  • Consensus broker forecasts and changes - based on data from over 300 contributing brokers
  • Sector statistics comparing each company with all the others in its peer group

Only REFS market rankings and individual profiles give you the complete investment picture.

Company REFS is available in two formats:

  • Online: With data and prices updated daily, you can easily sort and search for stocks that meet your investment criteria, as well as create personalised portfolios and watchlists.
  • Hard copy: Available as a monthly or quarterly edition, the hard copy of Company REFS comes in a handy ring binder format, with one page of per company – so you can easily compare stocks side by side.